Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03950570
Title ORIN1001 in Patients With Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Orinove, Inc.
Indications

Her2-receptor negative breast cancer

breast cancer

triple-receptor negative breast cancer

Advanced Solid Tumor

Therapies

ORIN1001 + Paclitaxel

ORIN1001

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Anschutz Medical Campus Recruiting Denver Colorado 80045 United States Details
Highlands Ranch Hospital Recruiting Highlands Ranch Colorado 80129 United States Details
University of Colorado Lone Tree Medical Center Recruiting Lone Tree Colorado 80124 United States Details
Gabrail Cancer Center Recruiting Canton Ohio 44718 United States Details
Sarah Cannon Research Institute Recruiting Nashville Tennessee 37203 United States Details
Baylor College of Medicine Medical Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field